LIDOCAINE ointment

देश: संयुक्त राज्य

भाषा: अंग्रेज़ी

स्रोत: NLM (National Library of Medicine)

सक्रिय संघटक:

LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987)

थमां उपलब्ध:

Glenmark Pharmaceuticals Inc., USA

INN (इंटरनेशनल नाम):

LIDOCAINE

रचना:

LIDOCAINE 50 mg in 1 g

प्रशासन का मार्ग:

TOPICAL

प्रिस्क्रिप्शन प्रकार:

PRESCRIPTION DRUG

चिकित्सीय संकेत:

Lidocaine ointment, 5% is indicated for production of anesthesia of accessible mucous membranes of the oropharynx. It is also useful as an anesthetic lubricant for intubation and for the temporary relief of pain associated with minor burns, including sunburn, abrasions of the skin, and insect bites. Lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type or to other components of lidocaine ointment, 5%.

उत्पाद समीक्षा:

Lidocaine Ointment USP, 5% is supplied as a white to off-white translucent, homogenous ointment and available in the following packs: Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].Manufactured by: Glenmark Pharmaceuticals Limited Colvale-Bardez, Goa 403 513, India Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430 Questions? 1 [phone] www.glenmarkpharma-us.com January 2020

प्राधिकरण का दर्जा:

Abbreviated New Drug Application

उत्पाद विशेषताएं

LIDOCAINE- LIDOCAINE OINTMENT
GLENMARK PHARMACEUTICALS INC., USA
----------
LIDOCAINE OINTMENT, 5% FOR TOPICAL USE
DO NOT USE IN THE EYES
RX ONLY
DESCRIPTION
Lidocaine Ointment USP, 5% contains a local anesthetic agent and is
administered
topically. See INDICATIONS AND USAGE for specific uses.
Lidocaine Ointment USP, 5% contains lidocaine USP, which is chemically
designated as
acetamide, 2-(diethylamino)-_N_-(2,6-dimethylphenyl)-, and has the
following structural
formula:
Composition of lidocaine ointment USP, 5%: acetamide,
2-(diethylamino)-_N_-(2,6-
dimethylphenyl)-, (lidocaine, USP) 5% in a water miscible ointment
vehicle containing
polyethylene glycols.
CLINICAL PHARMACOLOGY
MECHANISM OF ACTION
Lidocaine stabilizes the neuronal membrane by inhibiting the ionic
fluxes required for the
initiation and conduction of impulses, thereby effecting local
anesthetic action.
ONSET OF ANESTHESIA
Lidocaine ointment, 5% effects local, topical anesthesia. The onset of
action is 3 to 5
minutes. It is ineffective when applied to intact skin.
HEMODYNAMICS
Excessive blood levels may cause changes in cardiac output, total
peripheral resistance,
and mean arterial pressure. These changes may be attributable to a
direct depressant
effect of the local anesthetic agent on various components of the
cardiovascular
system.
PHARMACOKINETICS AND METABOLISM
Lidocaine may be absorbed following topical administration to mucous
membranes, its
rate and extent of absorption depending upon the specific site of
application, duration of
exposure, concentration, and total dosage. In general, the rate of
absorption of local
anesthetic agents following topical application occurs most rapidly
after intratracheal
administration. Lidocaine is also well-absorbed from the
gastrointestinal tract, but little
intact drug appears in the circulation because of biotransformation in
the liver.
Lidocaine is metabolized rapidly by the liver, and metabolites and
unchanged drug are
excreted by the kidneys. Biotransformation includes oxidative
N-dealkylation, ring
hy